IMAZIO, Massimo
 Distribuzione geografica
Continente #
NA - Nord America 9.304
AS - Asia 2.362
EU - Europa 1.812
Continente sconosciuto - Info sul continente non disponibili 1.578
SA - Sud America 576
AF - Africa 68
OC - Oceania 5
Totale 15.705
Nazione #
US - Stati Uniti d'America 8.897
IT - Italia 1.089
SG - Singapore 1.082
CN - Cina 456
BR - Brasile 435
CA - Canada 224
VN - Vietnam 217
HK - Hong Kong 171
DE - Germania 137
GB - Regno Unito 126
FR - Francia 120
BD - Bangladesh 117
IN - India 93
RU - Federazione Russa 69
NL - Olanda 57
AR - Argentina 51
KR - Corea 46
FI - Finlandia 32
EC - Ecuador 31
MX - Messico 30
ID - Indonesia 29
JP - Giappone 28
AT - Austria 25
IE - Irlanda 25
JM - Giamaica 25
CR - Costa Rica 24
ES - Italia 24
PL - Polonia 22
TT - Trinidad e Tobago 18
CO - Colombia 17
TR - Turchia 17
HN - Honduras 15
SV - El Salvador 14
ZA - Sudafrica 14
SE - Svezia 13
CL - Cile 12
DK - Danimarca 12
EE - Estonia 12
IL - Israele 12
SA - Arabia Saudita 12
PK - Pakistan 11
IQ - Iraq 10
KE - Kenya 10
PH - Filippine 10
PY - Paraguay 10
BB - Barbados 9
GR - Grecia 8
PR - Porto Rico 8
DO - Repubblica Dominicana 7
LT - Lituania 7
MA - Marocco 7
PT - Portogallo 7
SC - Seychelles 7
UZ - Uzbekistan 7
GT - Guatemala 6
MY - Malesia 6
NI - Nicaragua 6
UA - Ucraina 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
JO - Giordania 5
UY - Uruguay 5
AU - Australia 4
BO - Bolivia 4
BS - Bahamas 4
CH - Svizzera 4
DZ - Algeria 4
TG - Togo 4
AL - Albania 3
BG - Bulgaria 3
DM - Dominica 3
EG - Egitto 3
KZ - Kazakistan 3
LC - Santa Lucia 3
PE - Perù 3
SN - Senegal 3
TH - Thailandia 3
XK - ???statistics.table.value.countryCode.XK??? 3
AO - Angola 2
AZ - Azerbaigian 2
CG - Congo 2
CI - Costa d'Avorio 2
CY - Cipro 2
CZ - Repubblica Ceca 2
GD - Grenada 2
GY - Guiana 2
HT - Haiti 2
KH - Cambogia 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
LY - Libia 2
NP - Nepal 2
OM - Oman 2
TN - Tunisia 2
AD - Andorra 1
AG - Antigua e Barbuda 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BM - Bermuda 1
BW - Botswana 1
Totale 14.105
Città #
Council Bluffs 2.044
San Jose 1.538
Ashburn 1.067
Singapore 508
Boardman 292
Los Angeles 166
Hong Kong 165
Santa Clara 161
North Bergen 139
Phoenix 130
Dallas 128
Beijing 127
Milan 127
Rome 99
New York 88
Ho Chi Minh City 87
Pittsburgh 77
Naples 71
São Paulo 64
Lauterbourg 63
Chicago 58
Toronto 58
Atlanta 54
Mumbai 52
The Dalles 52
Buffalo 51
Hanoi 48
Hefei 46
Seoul 45
Montreal 38
Brooklyn 37
Bologna 36
Nuremberg 33
Turin 33
Frankfurt am Main 32
Las Vegas 32
Redondo Beach 31
Denver 27
Houston 26
Orem 25
Munich 24
Philadelphia 24
San Francisco 24
Bari 23
Helsinki 23
Roubaix 22
Tokyo 22
Amsterdam 21
The Bronx 21
Trieste 21
San José 20
Washington 19
Dublin 18
Vienna 18
Boston 17
Palermo 17
Queens 17
Rio de Janeiro 17
Charlotte 16
Florence 16
Genoa 16
Warsaw 16
Remanzacco 15
Seattle 14
Cleveland 13
Milwaukee 13
Cincinnati 12
Miami 12
Orlando 12
San Salvador 12
Chennai 11
Düsseldorf 11
Figino 11
Guayaquil 11
San Antonio 11
St Louis 11
Stockholm 11
Austin 10
Catania 10
Chandler 10
Jacksonville 10
Kingston 10
Mexico City 10
Quito 10
Udine 10
Brasília 9
Columbus 9
Curitiba 9
Da Nang 9
Haiphong 9
Manchester 9
Memphis 9
Minneapolis 9
Newark 9
Porto Alegre 9
San Diego 9
Baoding 8
Bridgetown 8
Changsha 8
Dhaka 8
Totale 8.778
Nome #
Drug-induced pericarditis: a systematic review of all published cases 411
INFLA-score: A new diagnostic paradigm to identify pericarditis 183
Pericardial Diseases: International Position Statement on New Concepts and Advances in Multimodality Cardiac Imaging 131
Aortic pseudoaneurysm with a fistula between the non-coronary sinus and right atrium: a case report 130
Eosinophilic myocarditis: comprehensive update on pathophysiology, diagnosis, prognosis and management 128
Diagnosis, Risk Stratification, and Treatment of Pericarditis: A Review 126
Colchicine in acute coronary syndromes: the present and the possible future 120
Colchicine for the treatment of the spectrum of cardiovascular diseases: Current evidence and ongoing perspectives 118
Machine-learning tool for classifying pulmonary hypertension via expert reader-provided CT features: An educational resource for non-dedicated radiologists 117
Management of cardiac sarcoidosis. A clinical consensus statement of the Heart Failure Association, the European Association of Cardiovascular Imaging, the ESC Working Group on Myocardial & Pericardial Diseases, and the European Heart Rhythm Association of the ESC 116
Persistence of fatigue in the absence of pathophysiological mechanisms in some patients more than 2 years after the original SARS-CoV-2 infection 113
[ANMCO Position paper: Care pathway for advanced heart failure patients candidate for heart transplantation/ventricular assist device] 111
Cardiac Magnetic Resonance Feature-Tracking Identifies Preclinical Abnormalities in Hypertrophic Cardiomyopathy Sarcomere Gene Mutation Carriers 111
The 2023 new European guidelines on infective endocarditis: Main novelties and implications for clinical practice 109
Asymptomatic Chronic Large Pericardial Effusions: To Drain or to Observe? 109
New Developments in the Management of Recurrent Pericarditis 107
Age-stratified patterns in clinical presentation, treatment and outcomes in acute pericarditis: a retrospective cohort study 107
Leflunomide-induced pulmonary arterial hypertension: Case report and review of literature 107
Critical approach to the 2023 European Society of Cardiology guidelines on cardiomyopathies: a document by the Working Group on Myocardial and Pericardial Diseases of the Italian Society of Cardiology 98
The impact of the European Society of Cardiology guidelines and whole exome sequencing on genetic testing in hereditary cardiac diseases 98
Anakinra-Dependent Recurrent Pericarditis: The Role of the R202Q Variant of the MEFV Gene 97
Distal Reoperations after Repair of Acute Type A Aortic Dissection—Incidence, Causes and Outcomes 97
Transthoracic echocardiography for arrhythmic mitral valve prolapse: Phenotypic characterization as first step 97
Sustained Pericarditis Recurrence Risk Reduction With Long-Term Rilonacept 93
Efficacy of colchicine in addition to anakinra in patients with recurrent pericarditis 92
Arrhythmic risk in acute myocarditis: Early threats, late events, and clinical uncertainty 89
Arrhythmic Risk Stratification of Carriers of Filamin C Truncating Variants 89
Characteristics, Prognosis, and European Society of Cardiology and European Respiratory Society Risk Stratification in Patients With Obesity and Pulmonary Arterial Hypertension 88
Myocarditis following COVID-19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document supported by the Heart Failure Association of the European Society of Cardiology (ESC) and the ESC Working Group on Myocardial and Pericardial Diseases 85
Sex differences in pulmonary arterial hypertension: Insights from the FOCUS-PAH registry 85
COVID-19 vaccines do not raise myocarditis and pericarditis incidence: Italian Society of Cardiology registry 84
Pregnancy in patients with inherited myocardial disorders – A consensus document on preconception counseling and pregnancy management by the working group on myocardial and pericardial disorders of the Italian Society of Cardiology 84
Duration of Disease and Long-Term Outcomes in Patients With Difficult-To-Treat Recurrent Pericarditis: A Chronic Condition Treated With Nonsteroidal Anti-Inflammatory Drugs, Colchicine, Corticosteroids, and Anti–Interleukin-1 Agents 84
Recurrent pericarditis in older adults: Clinical and laboratory features and outcome 80
Post-cardiac injury syndrome and pericardial effusion recurrence after pericardial effusion drainage in chronic idiopathic pericardial effusion 80
Inflammasome and ventricular arrhythmogenesis: Pathogenic interplay and potential targets on the horizon 78
ANMCO Position paper: Colchicine as a therapeutic agent in coronary syndromes 78
How to Use Interleukin-1 Antagonists in Patients With Pericarditis 76
Autoptic prevalence of pericarditis in coronavirus disease 2019 patients 75
ECG/echo indexes in the diagnostic approach to amyloid cardiomyopathy: A head-to-head comparison from the AC-TIVE study 75
Prognostic role of genetic variants in recurrent pericarditis 74
Comparative Efficacy and Safety of Colchicine and Anti–Interleukin- 1 Agents in Recurrent Pericarditis: A Pairwise and Network Meta- Analysis of Randomized Controlled Trials 73
Outcomes of acute pericarditis with an inflammatory phenotype 72
OPTImal PHARMacological therapy for patients with heart failure: Rationale and design of the OPTIPHARM-HF registry 72
Sudden cardiac death after acute myocarditis with arrhythmic presentation: Hunting for risk predictors - A systematic review and meta-analysis 72
Myocarditis and pericarditis in focus: A critical appraisal of the 2025 ESC vs ACC position statements from the Italian society of cardiology working group on cardiomyopathies and pericardial diseases 69
Inflammatory cardiomyopathy: Position paper of the Italian Society of Cardiology Working Group on cardiomyopathies and pericardial diseases in collaboration with the Italian Society of Cardiology Working Group on cardiac magnetic resonance 67
An update on the pathophysiology of acute and recurrent pericarditis 66
One stage extraction and reimplantation of ICD/PM in patients with CIED related endocarditis and spondiloscitis due to E. faecalis treated with double beta-lactam combination: ampicillin plus ceftobiprole 65
Colchicine for prevention of major adverse cardiovascular events: A meta-analysis of randomized clinical trials 65
Risk Stratification of Recurrent Pericarditis: Hype or Hope? 65
Pediatric Recurrent Pericarditis: Appropriateness of the Standard of Care and Response to IL-1 Blockade 65
Management of nonischemic-dilated cardiomyopathies in clinical practice: a position paper of the working group on myocardial and pericardial diseases of Italian Society of Cardiology 65
Scores for Risk Stratification of Pericarditis 64
Medical therapy of pericarditis: Tips and tricks for clinical practice 64
Advancing our understanding of cardiac tumors 64
Focus on 2023 ESC guidelines for the management of infective endocarditis: In light of new evidence 64
When heart team really counts: Radical excision of intracardiac leiomyomatosis 64
State of the art and perspectives of gene therapy in heart failure. A scientific statement of the Heart Failure Association of the ESC, the ESC Council on Cardiovascular Genomics and the ESC Working Group on Myocardial & Pericardial Diseases 61
Should we start using colchicine for secondary prevention of acute and chronic coronary syndromes after 2024 European society of cardiology guidelines? 59
Risk of incident pericarditis after coronavirus disease 2019 recovery: a systematic review and meta-analysis 59
Unveiling the Spectrum of Pericardial Diseases: Insights, Novelties, and Future Directions 58
CMR Findings Across Disease Phases in Takotsubo Syndrome: Insights From the Multicenter EVOLUTION Registry 57
Beyond the storm: rethinking recovery in fulminant myocarditis 57
Pericardial constrictive syndromes: a neglected cause of reversible heart failure 55
Prevention of pericardial complications after cardiac surgery: Myth or reality? 55
Dieci quesiti in tema di sarcoidosi cardiaca [Ten questions about cardiac sarcoidosis] 54
Catheter ablation to prevent malignant ventricular arrhythmias in symptomatic Brugada syndrome: A systematic review and meta-analysis 54
Myopericardial complications following COVID-19 disease and vaccination: a clinical consensus statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases 52
Efficacy and safety of colchicine for the treatment of myopericarditis 52
2025 ESC Guidelines for the management of myocarditis and pericarditis 51
Myosin-ATPase inhibitor in real-world patients with obstructive HCM: A report by the Cardiomyopathies and Pericardial Diseases WG of the Italian Society of Cardiology 50
2025 ESC Guidelines for the management of myocarditis and pericarditis 49
Natriuretic peptides to differentiate constrictive pericarditis and restrictive cardiomyopathy: A systematic review and meta-analysis 47
On the Road to Disclose the Pathogenesis of Pericarditis 47
Myocarditis: an increasing global health challenge! 47
Coping with recurrent pericarditis: bridging guidelines and clinical practice 45
Inflammation and genetics in myo-pericardial diseases: Insights from the Italian Study Group on Cardiomyopathies and Pericardial Diseases 44
Pericarditis at the crossroads: Unlocking the next wave of therapies 43
Inflammatory cardiomyopathy: an update for clinicians 41
HACEK Infective Endocarditis: Characteristics and Outcomes from a Large, Multi-National Cohort 41
Colchicine for Cardiovascular Prevention: Clarity Amidst the Confusion 41
The 2025 ESC myocarditis and pericarditis guidelines - what clinicians needs to know 39
Myocarditis and pericarditis exercise recommendations: a critical review of 2023 COCIS recommendations 38
Advances in Imaging and Targeted Therapies for Recurrent Pericarditis: A Review 38
Genetic variants in patients with recurrent pericarditis 38
Independent prognostic value of left ventricular stroke volume index in patients with takotsubo syndrome: insights from the EVOLUTION registry 38
Physical triggers in takotsubo syndrome: a high-risk phenotype? insights from the eVOLUTION registry 38
Adipose Tissue in and Around the Heart: Structural and Functional Insights from Cardiac Magnetic Resonance 37
Good Prognosis for Pericarditis With and Without Myocardial Involvement: Results From a Multicenter, Prospective Cohort Study 37
Comparative analysis of recurrence rates following various cessation strategies for rilonacept in recurrent pericarditis 36
Change in prevalence of ATTR variants in Italy: Results from a national survey 35
Contemporary medical therapy for heart failure across the ejection fraction spectrum: The OPTIPHARM-HF registry 34
The role of cardiovascular multimodality imaging in the evaluation of Anderson-Fabry disease: From early diagnosis to therapy monitoring 34
Recurrent pain without objective evidence of disease in patients with previous idiopathic or viral acute pericarditis 34
Use of anakinra during pregnancy and breastfeeding in women with recurrent pericarditis: A case series 33
Epidemiological Changes and Improvement in Outcomes of Infective Endocarditis in Europe in the Twenty-First Century: An International Collaboration on Endocarditis (ICE) Prospective Cohort Study (2000–2012) 33
A Randomized Trial of Colchicine for Acute Pericarditis 33
Recurrent pericarditis with normal C-reactive protein: Clinical and laboratory features, biomarkers and outcome in a non-inflammatory phenotype 32
Evaluation and Treatment of Pericarditis: A Systematic Review 32
Totale 7.424
Categoria #
all - tutte 58.288
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.288


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222 0 0 0 0 0 0 0 0 0 0 1 1
2022/202345 1 0 0 9 7 10 0 3 2 1 9 3
2023/2024134 2 2 33 15 8 7 1 13 7 11 19 16
2024/20251.237 35 67 52 87 67 55 66 66 184 98 214 246
2025/20267.484 239 358 465 444 392 245 250 149 978 1.606 1.508 850
2026/20276.796 598 1.272 1.526 3.400 0 0 0 0 0 0 0 0
Totale 15.705